OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	75
Improving Medication Adherence in Asthma	73
Pneumonia After Solid Organ Transplantation	54
Sleep, Circadian Rhythms, and Lung Cancer	53
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	47
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	45
Mechanical Ventilation for COVID-19 Patients	38
	36
Diffuse Alveolar Hemorrhage (DAH)	33
Severe Infections Due to Respiratory Viruses	25
Nonmalignant Pleural Effusions	25
	23
Impact of Marijuana Use on Lung Health	22
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	18
Prevention of Aspiration: Oral Care, Antibiotics, Others	17
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	17
Indwelling Pleural Catheter: Management of Complications	16
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	16
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	16
Imaging in the Intensive Care Unit	16
Lung Transplant for Chronic Obstructive Pulmonary Disease	16
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	16
	16
Management of Dyspnea in Patients with Neuromuscular Disorders	15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	14

Deployment-Related Respiratory Disease: Where Are We?	13
COVID-19-Related Pleural Diseases	13
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	12
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	12
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	12
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	12
	12
Definition and Epidemiology of Sepsis	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
Pulmonary Physiology and Medicine of Diving	11
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	11
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Lung Cancer in Special Populations	10
Work-Related Sleep Disorders: Causes and Impacts	10
Understanding the Updates in the Asthma Guidelines	10
Bronchoscopic Lung Volume Reduction: A Review	10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	10
How to Survive Sepsis: Patient Testimonial	10
Survivorship Challenges and Supportive Care in Lung Cancer	10
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Management of Acutely Decompensated Pulmonary Hypertension	9
Updates in Lung Cancer Screening: A Decade of Evidence	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Malignant Central Airway Obstruction: What's New?	8
Pertussis Vaccination: The Challenges Ahead	8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Corticosteroid Treatment in Septic Shock	8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7
Arterial Blood Gases and Acid–Base Regulation	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
Intra-abdominal Infections	7
	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Aspergillus and the Lung	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Severe Community-Acquired Pneumonia	7
“Long Haulers”	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6

Pulmonary Hypertension Associated with Left Heart Disease	6
HIV and COVID-19 Disease	6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Use of Antiviral Agents and other Therapies for COVID-19	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Aspiration Pneumonia: Preface	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6
Control of Breathing	6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6